Profile: Elixir Medical Corporation develops products that combine medical devices with pharmaceuticals to provide treatment solutions. Drug-eluting stent systems are designed to optimize localized drug delivery to provide a safe treatment for cardiovascular patients. Our coronary stent is manufactured from a cobalt chromium alloy, which is used in vascular implants. Cobalt chromium offers strength & improved visualization under fluoroscopy compared to stents made from stainless steel. Our coronary stent has 33 percent lower strut thickness than a stainless steel stent, without compromising radial strength & radiopacity. Our Novolimus™ is a mTOR inhibitor macro-cyclic lactone with anti-proliferative & anti-inflammatory properties developed for drug eluting stents.
FDA Registration Number: 3005092783
15 Products/Services (Click for related suppliers)
|
| • Bioabsorbable Hernia Plug |
| • Bioabsorbable synthetic spacers |
| • Coronary Covered Stent (FDA Code: NIV) |
| • Coronary Drug-Eluting Stent (FDA Code: NIQ) |
| • Coronary Stainless Steel Stents |
| • Coronary Stent (FDA Code: MAF) |
| • Coronary Stent Graft System |
| • Coronary Stent Systems |
| • Drug Eluting Stent Systems |
| • Fully Bioabsorbable Drug Eluting Stent Systems |
| • Pharmaceutical Items |
| • Pharmaceuticals |
| • Small Vessel Coronary Stent Systems |
| • Stainless Steel and Cobalt Chromium Molybdenum Compression Hip Screws |
| • Stent Delivery Systems |